Effectiveness and Safety of Oral Tofacitinib in Patients with Recalcitrant Frontal Fibrosing Alopecia: A Pilot Study

Published: 21 April 2025| Version 2 | DOI: 10.17632/cwjxcdp9gv.2
Contributors:
Wipawan Vathananai, Viyada Tamprateep, Phanitchanat Phusuphitchayanan, Chinmanat Lekhavat

Description

Mendeley Supplementary Figure 1. Clinical photographs of a patient with refractory FFA, showing the eyebrows before (3A) and after (3B) 12 weeks of oral tofacitinib therapy. Notable improvements include increased eyebrow density and length.

Files

Institutions

  • Institute of Dermatology

Categories

Hair Disorder, Alopecia, Management of Hair Loss Symptom, Hair Loss

Licence